New York
Phase 1 cancer trials in New York
298 Phase 1 cancer studies are recruiting participants at sites in 30 cities across New York as of November 17, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Every New York city with a recruiting study
By research area: Breast Cancer (83), Lung Cancer (82), Lymphoma (68), Prostate Cancer (33), Pancreatic Cancer (18), Melanoma (14).
New York (247), Buffalo (26), Commack (24), Harrison (23), Lake Success (22), Mineola (17), The Bronx (17), Uniondale (17), New Hyde Park (8), Rochester (8), Rockville Centre (7), Brooklyn (6), Valhalla (6), Long Island City (4), Port Jefferson Station (3), Shirley (3), Stony Brook (3), Syracuse (3), Westbury (3), Albany (1), Amsterdam (1), Babylon (1), East Patchogue (1), East Syracuse (1), Garden City (1), Manhattan (1), Patchogue (1), Riverhead (1), Vallhala (1), White Plains (1).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
Breast cancer: recently updated in New York
Basic details from each study's public record (the 12 most recently updated of 298). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Phase 1/2 Study of IAM1363 in HER2 Cancers
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Iambic Therapeutics, Inc
- Recruiting in
- New York
- Registry record
- NCT06253871 · updated
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Aktis Oncology, Inc.
- Recruiting in
- New York
- Registry record
- NCT07020117 · updated
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Boehringer Ingelheim
- Recruiting in
- New York · Shirley
- Registry record
- NCT06324357 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in New York on ClinicalTrials.gov.
Lung cancer: recently updated in New York
Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Vivace Therapeutics, Inc
- Recruiting in
- New York
- Registry record
- NCT04665206 · updated
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Institut de Recherches Internationales Servier
- Recruiting in
- New York
- Registry record
- NCT05786924 · updated
A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- EpiBiologics
- Recruiting in
- Lake Success
- Registry record
- NCT07462377 · updated
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- New York
- Registry record
- NCT06287775 · updated
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
- Phase 1
- Ages 18 to 99
- All sexes
- Sponsor
- Erasca, Inc.
- Recruiting in
- New York
- Registry record
- NCT06983743 · updated
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- IDEAYA Biosciences
- Recruiting in
- New York
- Registry record
- NCT07277413 · updated
A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Astellas Pharma Global Development, Inc.
- Recruiting in
- Lake Success
- Registry record
- NCT07730021 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in New York on ClinicalTrials.gov.
Lymphoma: recently updated in New York
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Phase 1/2
- Up to age 22
- All sexes
- Sponsor
- PedAL BCU, LLC
- Recruiting in
- Albany · Brooklyn · Mineola · and 6 more U.S. locations
- Registry record
- NCT04726241 · updated
A Study of Zedoresertib (Debio 0123) in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Zedoresertib (Debio 0123) in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Debiopharm International SA
- Recruiting in
- New York
- Registry record
- NCT05765812 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in New York on ClinicalTrials.gov.
Ask about studies in New York
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.
Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections